Literature DB >> 22589888

4,7,8-Trimethyl-2H-chromen-2-one.

Jian-Xin Yang, Xue-Mei Tan, Xiang-Hui Wang, Yin Wang.   

Abstract

The mol-ecule of the title compound, C(12)H(12)O(2), is essentially planar, with a maximum deviation from the mean plane of all non-H atoms of 0.038 (1) Å for the methyl C atom in the 8-position. The crystal structure is characterized by anti-parallel π-π stacking along the c axis, with centroid-centroid distances as short as 3.866 (1) Å. In the crystal, C-H⋯O hydrogen bonds connect the mol-ecules across the stacks into ribbons in the a-axis direction.

Entities:  

Year:  2012        PMID: 22589888      PMCID: PMC3343979          DOI: 10.1107/S1600536812009646

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For general background to the pharmacological activity of coumarin derivatives, see: Xie et al. (2001 ▶); Tanitame et al. (2004 ▶); Shao et al. (1997 ▶); Rendenbach-Müller et al. (1994 ▶); Pochet et al. (1996 ▶). For a related structure, see: Gowda et al. (2010 ▶).

Experimental

Crystal data

C12H12O2 M = 188.22 Monoclinic, a = 7.276 (3) Å b = 18.075 (6) Å c = 7.246 (3) Å β = 97.055 (5)° V = 945.8 (6) Å3 Z = 4 Mo Kα radiation μ = 0.09 mm−1 T = 153 K 0.44 × 0.31 × 0.26 mm

Data collection

Rigaku AFC10/Saturn724+ diffractometer 8545 measured reflections 2747 independent reflections 2176 reflections with I > 2σ(I) R int = 0.028

Refinement

R[F 2 > 2σ(F 2)] = 0.050 wR(F 2) = 0.112 S = 1.00 2747 reflections 130 parameters H-atom parameters constrained Δρmax = 0.28 e Å−3 Δρmin = −0.33 e Å−3 Data collection: CrystalClear (Rigaku, 2008 ▶); cell refinement: CrystalClear; data reduction: CrystalClear; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶) and OLEX2 (Dolomanov et al., 2009 ▶); software used to prepare material for publication: SHELXTL and publCIF (Westrip, 2010 ▶). Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S1600536812009646/ld2048sup1.cif Structure factors: contains datablock(s) I. DOI: 10.1107/S1600536812009646/ld2048Isup2.hkl Supplementary material file. DOI: 10.1107/S1600536812009646/ld2048Isup3.cml Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C12H12O2F(000) = 400
Mr = 188.22Dx = 1.322 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
a = 7.276 (3) ÅCell parameters from 3283 reflections
b = 18.075 (6) Åθ = 2.3–30.0°
c = 7.246 (3) ŵ = 0.09 mm1
β = 97.055 (5)°T = 153 K
V = 945.8 (6) Å3Prism, colorless
Z = 40.44 × 0.31 × 0.26 mm
Rigaku AFC10/Saturn724+ diffractometer2176 reflections with I > 2σ(I)
Radiation source: Rotating AnodeRint = 0.028
Graphite monochromatorθmax = 30.1°, θmin = 3.1°
Detector resolution: 28.5714 pixels mm-1h = −9→10
phi and ω scansk = −24→25
8545 measured reflectionsl = −10→10
2747 independent reflections
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.050Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.112H-atom parameters constrained
S = 1.00w = 1/[σ2(Fo2) + (0.0269P)2 + 0.551P] where P = (Fo2 + 2Fc2)/3
2747 reflections(Δ/σ)max = 0.001
130 parametersΔρmax = 0.28 e Å3
0 restraintsΔρmin = −0.33 e Å3
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
H20.83640.03750.99620.029*
H50.43460.23560.83890.030*
H60.47080.36290.84970.030*
H10A0.53360.03810.86160.035*
H10B0.47260.10970.73920.035*
H10C0.41830.10260.94590.035*
H11A0.64320.46980.91530.037*
H11B0.85810.46250.89140.037*
H11C0.79410.46341.09490.037*
H12A1.15050.31391.17560.036*
H12B1.06320.39531.16930.036*
H12C1.14830.36330.99210.036*
C11.01364 (18)0.12436 (7)1.07922 (18)0.0243 (3)
C20.84235 (18)0.08992 (7)1.00252 (18)0.0244 (3)
C30.69054 (18)0.12937 (7)0.93951 (18)0.0224 (3)
C40.69972 (17)0.20939 (7)0.94548 (17)0.0207 (2)
C50.55137 (18)0.25623 (7)0.88512 (19)0.0248 (3)
C60.57298 (19)0.33200 (7)0.89207 (19)0.0251 (3)
C70.74262 (18)0.36425 (7)0.96038 (18)0.0234 (3)
C80.89411 (18)0.31925 (7)1.02295 (18)0.0221 (3)
C90.86750 (17)0.24271 (7)1.01382 (17)0.0206 (2)
C100.51347 (19)0.09170 (8)0.8651 (2)0.0296 (3)
C110.7611 (2)0.44726 (7)0.9660 (2)0.0305 (3)
C121.08022 (19)0.35066 (8)1.0964 (2)0.0299 (3)
O11.02050 (12)0.20031 (5)1.07807 (13)0.0240 (2)
O21.15405 (14)0.09227 (6)1.14331 (15)0.0338 (3)
U11U22U33U12U13U23
C10.0259 (6)0.0213 (6)0.0259 (6)0.0034 (5)0.0042 (5)−0.0003 (5)
C20.0277 (7)0.0189 (6)0.0268 (6)−0.0011 (5)0.0041 (5)−0.0012 (5)
C30.0246 (6)0.0225 (6)0.0205 (6)−0.0035 (5)0.0040 (5)−0.0007 (5)
C40.0213 (6)0.0211 (6)0.0200 (6)−0.0004 (4)0.0038 (5)−0.0002 (5)
C50.0202 (6)0.0273 (6)0.0262 (6)−0.0003 (5)0.0001 (5)0.0003 (5)
C60.0238 (6)0.0258 (6)0.0254 (6)0.0048 (5)0.0014 (5)0.0024 (5)
C70.0276 (6)0.0204 (6)0.0223 (6)0.0014 (5)0.0039 (5)0.0018 (5)
C80.0223 (6)0.0222 (6)0.0220 (6)−0.0010 (5)0.0028 (5)0.0000 (5)
C90.0196 (6)0.0209 (6)0.0214 (6)0.0018 (4)0.0025 (5)0.0007 (5)
C100.0283 (7)0.0267 (7)0.0329 (7)−0.0080 (5)0.0006 (6)−0.0005 (6)
C110.0366 (8)0.0209 (6)0.0335 (8)0.0024 (5)0.0016 (6)0.0023 (5)
C120.0265 (7)0.0257 (7)0.0359 (7)−0.0052 (5)−0.0021 (6)−0.0010 (6)
O10.0205 (4)0.0212 (4)0.0296 (5)0.0020 (3)−0.0004 (4)0.0000 (4)
O20.0287 (5)0.0271 (5)0.0439 (6)0.0075 (4)−0.0030 (4)−0.0006 (4)
C1—C21.4421 (19)C8—C121.5042 (18)
C2—H20.9500C10—H10A0.9800
C2—C31.3465 (18)C10—H10B0.9800
C3—C41.4484 (18)C10—H10C0.9800
C3—C101.4979 (18)C11—H11A0.9800
C4—C51.3990 (18)C11—H11B0.9800
C4—C91.3964 (17)C11—H11C0.9800
C5—H50.9500C12—H12A0.9800
C5—C61.3788 (19)C12—H12B0.9800
C6—H60.9500C12—H12C0.9800
C6—C71.3994 (19)O1—C11.3739 (16)
C7—C81.3998 (18)O1—C91.3842 (15)
C7—C111.5067 (19)O2—C11.2163 (16)
C8—C91.3973 (18)
O1—C1—C2117.34 (11)C9—C8—C12120.26 (12)
O2—C1—C2125.95 (13)C4—C9—C8123.63 (11)
O2—C1—O1116.71 (12)O1—C9—C4120.83 (11)
C1—C2—H2118.8O1—C9—C8115.54 (11)
C3—C2—H2118.8H10A—C10—H10B109.5
C3—C2—C1122.43 (12)H10A—C10—H10C109.5
C2—C3—C4119.07 (12)H10B—C10—H10C109.5
C2—C3—C10120.99 (12)C3—C10—H10A109.5
C4—C3—C10119.94 (12)C3—C10—H10B109.5
C5—C4—C3124.33 (12)C3—C10—H10C109.5
C9—C4—C3118.45 (11)H11A—C11—H11B109.5
C9—C4—C5117.21 (12)H11A—C11—H11C109.5
C4—C5—H5119.7H11B—C11—H11C109.5
C6—C5—H5119.7C7—C11—H11A109.5
C6—C5—C4120.63 (12)C7—C11—H11B109.5
C5—C6—H6119.4C7—C11—H11C109.5
C5—C6—C7121.22 (12)H12A—C12—H12B109.5
C7—C6—H6119.4H12A—C12—H12C109.5
C6—C7—C8119.86 (12)H12B—C12—H12C109.5
C6—C7—C11119.76 (12)C8—C12—H12A109.5
C8—C7—C11120.39 (12)C8—C12—H12B109.5
C7—C8—C12122.29 (12)C8—C12—H12C109.5
C9—C8—C7117.45 (12)C1—O1—C9121.80 (10)
D—H···AD—HH···AD···AD—H···A
C2—H2···O2i0.952.563.460 (2)159
C10—H10C···O2ii0.982.543.493 (2)164
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
C2—H2⋯O2i0.952.563.460 (2)159
C10—H10C⋯O2ii0.982.543.493 (2)164

Symmetry codes: (i) ; (ii) .

  5 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  Esters and amides of 6-(chloromethyl)-2-oxo-2H-1-benzopyran-3-carboxylic acid as inhibitors of alpha-chymotrypsin: significance of the "aromatic" nature of the novel ester-type coumarin for strong inhibitory activity.

Authors:  L Pochet; C Doucet; M Schynts; N Thierry; N Boggetto; B Pirotte; K Y Jiang; B Masereel; P de Tullio; J Delarge; M Reboud-Ravaux
Journal:  J Med Chem       Date:  1996-06-21       Impact factor: 7.446

3.  Anti-AIDS agents. 42. Synthesis and anti-HIV activity of disubstituted (3'R,4'R)-3',4'-di-O-(S)-camphanoyl-(+)-cis-khellactone analogues.

Authors:  L Xie; Y Takeuchi; L M Cosentino; A T McPhail; K H Lee
Journal:  J Med Chem       Date:  2001-03-01       Impact factor: 7.446

4.  Synthesis and antibacterial activity of a novel series of potent DNA gyrase inhibitors. Pyrazole derivatives.

Authors:  Akihiko Tanitame; Yoshihiro Oyamada; Keiko Ofuji; Mika Fujimoto; Noritaka Iwai; Yoichi Hiyama; Kenji Suzuki; Hideaki Ito; Hideo Terauchi; Motoji Kawasaki; Kazuo Nagai; Masaaki Wachi; Jun-ichi Yamagishi
Journal:  J Med Chem       Date:  2004-07-01       Impact factor: 7.446

5.  4-Bromo-methyl-7,8-dimethyl-coumarin.

Authors:  Ramakrishna Gowda; K V Arjuna Gowda; Mahantesha Basanagouda; Manohar V Kulkarni
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.